Shanghai Rendu Biotechnology Co

Shanghai Rendu Biotechnology Co Cash Flow per Share

The Operating Cash Flow per Share of Shanghai Rendu Biotechnology Co (688193.SS) as of Oct 17, 2026 is 0.56 CNY. In the previous year, Operating Cash Flow per Share was 0.61 CNY — a change of -8.12% (lower).

Cash Flow per Share

0.56CNY

YoY

-8.12%

Last updated:

Operating Cash Flow per Share of Shanghai Rendu Biotechnology Co is 2025 0.56 CNY. Operating Cash Flow per Share of Shanghai Rendu Biotechnology Co was 2024 0.61 CNY. It decreases by -8.12% lower compared to the previous year.

The Shanghai Rendu Biotechnology Co Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-0.06 CNY
Jan 1, 2019
0.34 CNY
Jan 1, 2020
2.32 CNY
Jan 1, 2021
1.36 CNY
Jan 1, 2022
-0.10 CNY
Jan 1, 2023
0.43 CNY
Jan 1, 2024
0.61 CNY
Jan 1, 2025
0.56 CNY
The Shanghai Rendu Biotechnology Co Cash Flow per Share history
YEARCash Flow per ShareYoY
0.56CNY-8.12%
0.61CNY+41.85%
0.43CNY-520.21%
-0.10CNY-107.51%
1.36CNY-41.21%
2.32CNY+577.69%
0.34CNY-675.55%
-0.06CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co Ltd develops molecular diagnostic tests using RNA isothermal amplification technology, offering reagents for respiratory, reproductive, enterovirus, and blood-borne disease diagnostics. Headquartered in Shanghai, China, the company employs 528 full-time staff and operates primarily within the domestic market. Listed on March 30, 2022, it designs and manufactures medical instruments alongside its diagnostic products. Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Operating Cash Flow per Share of Shanghai Rendu Biotechnology Co is 0.56 CNY in 2025.

Operating Cash Flow per Share of Shanghai Rendu Biotechnology Co changed from 0.61 CNY to 0.56 CNY, representing a -8.12% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Shanghai Rendu Biotechnology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Shanghai Rendu Biotechnology Co